Patents by Inventor Robert Heintz
Robert Heintz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9764875Abstract: Methods for protecting a ground surface from exposure to material that may be spilled from or leak from one or more containers, which includes setting up a portable spill containment system that includes at least one grate for supporting the one or more containers. The grate includes a plurality of drain holes. The portable spill containment system includes a flexible bag configured to contain spills or leakage from the one or more containers that pass through the drain holes of the grate. In one embodiment, the portable spill containment system includes a plurality of pedestals that support the at least one grate. In another embodiment, the portable spill containment system includes an interconnected grid structure formed of separate and distinct spaced apart beams.Type: GrantFiled: September 17, 2015Date of Patent: September 19, 2017Assignee: ENPAC, L.L.C.Inventors: Lawrence Stanek, Jay Wiley, Robert Heintz, Scott Janda, Timothy Reed
-
Publication number: 20160001920Abstract: Methods for protecting a ground surface from exposure to material that may be spilled from or leak from one or more containers, which includes setting up a portable spill containment system that includes at least one grate for supporting the one or more containers. The grate includes a plurality of drain holes. The portable spill containment system includes a flexible bag configured to contain spills or leakage from the one or more containers that pass through the drain holes of the grate. In one embodiment, the portable spill containment system includes a plurality of pedestals that support the at least one grate. In another embodiment, the portable spill containment system includes an interconnected grid structure formed of separate and distinct spaced apart beams.Type: ApplicationFiled: September 17, 2015Publication date: January 7, 2016Inventors: Lawrence Stanek, Jay Wiley, Robert Heintz, Scott Janda, Timothy Reed
-
Patent number: 9150350Abstract: A portable spill containment system that includes at least one grate that supports a container. The grate includes a plurality of drain holes. The portable spill containment system also includes a flexible bag that contains leakage from the container that passes through the drain holes of the grate. The portable spill containment system also includes a plurality of pedestals that support the at least one grate.Type: GrantFiled: February 21, 2013Date of Patent: October 6, 2015Assignee: ENPAC LLCInventors: Lawrence Stanek, Jay Wiley, Robert Heintz, Scott Janda, Timothy Reed
-
Publication number: 20150014325Abstract: A portable spill containment system that includes at least one grate that supports a container. The grate includes a plurality of drain holes. The portable spill containment system also includes a flexible bag that contains leakage from the container that passes through the drain holes of the grate. The portable spill containment system also includes a plurality of pedestals that support the at least one grate.Type: ApplicationFiled: February 21, 2013Publication date: January 15, 2015Applicant: ENPAC, L.L.C.Inventors: Lawrence Stanek, Jay Wiley, Robert Heintz, Scott Janda, Timothy Reed
-
Publication number: 20080103311Abstract: N-heterocyclic moiety containing hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.Type: ApplicationFiled: December 11, 2007Publication date: May 1, 2008Applicant: Pharmacia CorporationInventors: John Tally, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
-
Publication number: 20070078173Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.Type: ApplicationFiled: September 25, 2006Publication date: April 5, 2007Applicant: G.D. Searle & Co.Inventors: Michael Vazquez, Richard Mueller, John Talley, Daniel Getman, Gary DeCrescenzo, John Freskos, Robert Heintz, Deborah Bertenshaw
-
Publication number: 20070015818Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.Type: ApplicationFiled: July 5, 2006Publication date: January 18, 2007Applicants: G.D. Searle & Co. (now G.D. Searle, LLC), Monsanto Company (now Pharmacia Corporation)Inventors: Deborah Bertenshaw, Daniel Getman, Robert Heintz, John Talley, Kathryn Reed, Robert Chrusciel, Michael Clare
-
Publication number: 20060276493Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as-inhibitors of HIV protease.Type: ApplicationFiled: May 15, 2006Publication date: December 7, 2006Applicant: G.D Searle & Co.Inventors: Michael Vasquez, Richard Mueller, John Talley, Daniel Getman, Gary DeCrescenzo, John Freskos, Deborah Bertenshaw, Robert Heintz
-
Publication number: 20060166895Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.Type: ApplicationFiled: January 13, 2006Publication date: July 27, 2006Applicant: Monsanto Company (now named Pharmacia Corporation, which is a wholly owned subsidiary of Pfizer, IncInventors: John Talley, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
-
Publication number: 20060074243Abstract: This invention is directed generally to hydroxamic acid and amide compounds (including salts of such compounds), and, more particularly, to aryl- and heteroaryl-arylsulfonylmethyl hydroxamic acids and amides that, inter alia, inhibit protease activity, particularly matrix metalloproteinase (also known as “matrix metalloprotease” or “MMP”) activity and/or aggrecanase activity. These compounds generally correspond in structure to Formula I: wherein A1, A2, A3, E1, E2, E3, and E4 are as defined in this patent. This invention also is directed to compositions of such compounds, intermediates for the syntheses of such compounds, methods for making such compounds, and methods for treating conditions associated with MMP activity and/or aggrecanase activity, particularly pathological conditions.Type: ApplicationFiled: November 10, 2005Publication date: April 6, 2006Inventors: Daniel Becker, Yiyuan Chen, John Freskos, Alan Gasiecki, Margaret Grapperhaus, Donald Hansen, Robert Heintz, Darren Kassab, Ish Khanna, Stephen Kolodziej, Sergio Mantegani, Mark Massa, Joseph McDonald, Deborah Mischke, Mark Nagy, Ettore Perrone, Joseph Rico, Michelle Schmidt, Dale Spangler, John Talley, Mahima Trivedi, Thomas Wynn
-
Publication number: 20060010492Abstract: Methods and systems are disclosed for monitoring activity of a user on a network component, such as an end user computer, in a virtual private network for adherence to a security enforcement provision or policy utilized in the virtual private network. A method of determining whether a security provision in a computer network has been violated is described. It is determined whether the network component has violated, modified or circumvented a security enforcement provision of the computer network. If the detection is affirmative, the network component, such as an end user system, is modified in a manner in which the computer network operates at a level appropriate to the degree of the violation, modification, or circumvention of the security enforcement provision. If instructed to do so, a third party operating the virtual private network is notified of the violation and access to the network by the network component is restricted or terminated.Type: ApplicationFiled: June 10, 2002Publication date: January 12, 2006Inventors: Robert Heintz, Jeffrey Christy
-
Publication number: 20050267171Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.Type: ApplicationFiled: April 21, 2005Publication date: December 1, 2005Applicant: G.D. Searle & Co.Inventors: Michael Vazquez, Richard Mueller, John Talley, Daniel Getman, Gary DeCrescenzo, John Freskos, Deborah Bertenshaw, Robert Heintz
-
Publication number: 20050119257Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.Type: ApplicationFiled: September 2, 2004Publication date: June 2, 2005Applicants: G.D. Searle & Co., Pharmacia Corporation (Monsanto Company)Inventors: Deborah Bertenshaw, Daniel Getman, Robert Heintz, John Talley, Kathryn Reed, Robert Chrusciel, Michael Clare
-
Publication number: 20050014840Abstract: This invention is directed to proteinase (protease) inhibitors, and more particularly to thiol sulfonamide inhibitors for matrix metalloproteinase 13(MMP-13), compositions of proteinase inhibitors, intermediates for the syntheses of proteinase inhibitors, processes for the preparation of proteinase inhibitors and processes for treating pathological conditions associated with pathological matrix metalloproteinase activity related to MMP-13.Type: ApplicationFiled: May 4, 2004Publication date: January 20, 2005Inventors: Zaheer Abbas, Gary DeCrescenzo, John Freskos, Daniel Getman, Robert Heintz, Joseph McDonald, Brent Mischke
-
Publication number: 20050009838Abstract: This invention is directed generally to proteinase (also known as “protease”) inhibitors, and, more particularly, to piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids that, inter alia, inhibit matrix metalloproteinase (also known as “matrix metalloprotease” or “MMP”) activity and/or aggrecanase activity. Such hydroxamic acids generally correspond in structure to the following formula: (wherein A1, A2, Y, E1, E2, E3, and Rx are as defined in this specification), and further include salts of such compounds. This invention also is directed to compositions of such hydroxamic acids, intermediates for the syntheses of such hydroxamic acids, methods for making such hydroxamic acids, and methods for treating conditions (particularly pathological conditions) associated with MMP activity and/or aggrecanase activity.Type: ApplicationFiled: April 25, 2003Publication date: January 13, 2005Inventors: Thomas Barta, Daniel Becker, Louis Bedell, Terri Boehm, David Brown, Jeffery Carroll, Yiyuan Chen, Yvette Fobian, John Freskos, Alan Gasiecki, Margaret Grapperhaus, Robert Heintz, Susan Hockerman, Darren Kassab, Ish Khanna, Stephen Kolodziej, Mark Massa, Joseph McDonald, Brent Mischke, Deborah Mischke, Patrick Mullins, Mark Nagy, Monica Norton, Joseph Rico, Michelle Schmidt, Nathan Stehle, John Talley, William Vernier, Clara Villamil, Lijuan Wang, Thomas Wynn
-
Publication number: 20050004230Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.Type: ApplicationFiled: March 5, 2004Publication date: January 6, 2005Applicant: Monsanto Company (now named Pharmacia Corporation, which is a wholly owned subsidiary of Pfizer, IncInventors: John Talley, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
-
Patent number: 4286954Abstract: A method of folding an inflatable restraint cushion for storage in a support housing which is mountable to the lower portion of the instrument panel of a vehicle. The method involves forming pleats in the cushion in a manner that, during initial deployment, the cushion mass acting on an occupant located in the proximity of the instrument panel is reduced.Type: GrantFiled: December 3, 1979Date of Patent: September 1, 1981Assignee: General Motors CorporationInventors: Donald N. McArthur, Robert A. Heintz